Choosing Blood Thinners for Clotting Tests Using PFA-200
Part of Blood & lymphatic clinical trials.
This study looks at how well a blood test (PFA-200) works to check clotting in people who take different types of blood thinners. You don't need any extra procedures—just your regular blood draw.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a scheduled appointment for a bleeding disorder check-up (hemostasis consultation) where your doctor has ordered a standard PFA blood test.
- You are not pregnant, breastfeeding, or recently gave birth.
- You are not under legal guardianship or any court protection order.
- You are willing to let your regular blood sample results be used for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new lab device that measures how well your body forms primary blood clots while blood is kept in flowing conditions. It may help doctors better assess bleeding or clotting tendencies and guide future care.
This study tests a new quick blood-clotting test (point-of-care INR testing) for patients with antiphospholipid syndrome who take blood thinners. The goal is to see if this faster test works as well as standard lab tests for monitoring their treatment.
This trial is collecting blood from healthy adults to establish a new reference range for a standard platelet function test. You may be eligible if you do not have any bleeding disorders, are not taking blood thinners or anti-inflammatory medications, and meet other lab criteria.
This trial uses stored blood samples to see how well different lab tests measure clotting when someone has a factor deficiency (like low levels of clotting proteins) or liver damage. It may help doctors choose the most accurate test for these situations.
This trial compares different blood test reagents to see which works best for measuring clotting time in people with clotting factor deficiencies or liver disease. It may help doctors choose the right test for your condition.
This study compares two ways of filtering your blood (plasmapheresis) to see how each affects your blood's ability to clot. If you already receive regular plasmapheresis with citrate, you might help doctors learn which method is safer for you.
Hear when a new Hemostasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.